The Patent Finder

Armata Pharmaceuticals, Inc.

9 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Ampliphi Biosciences Corporation (to 2019)

0
Ending by 2030
Nov 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 30, 2027
    The maintenance fee for Therapeutic Bacteriophage Compositions (US 10,517,908) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

PatentTitleStatus Expires Confidence
US 9,623,058Novel Bacteriophages
In force
 · High confidence
In forceHigh confidence
US 10,517,908Therapeutic Bacteriophage Compositions
In force
 · High confidence
In forceHigh confidence
US 11,654,166Therapeutic Bacteriophage Compositions for Treating Staphylococcus Infection
In force
 · High confidence
In forceHigh confidence
US 12,503,687Therapeutic Bacteriophage Compositions
In force
 · Low confidence
In forceLow confidence
US 11,253,557Therapeutic Bacteriophage Compositions
In force
 · High confidence
In forceHigh confidence
US 12,239,677Therapeutic Bacteriophage Compositions for Treating Staphylococcus Infection
In force
 · High confidence
In forceHigh confidence
US 12,751,983Bacteriophage Compositions for Treating Staphylococcus Infection
In force
 · High confidence
In forceHigh confidence
US 12,268,720Bacteriophage for treatment and prevention of E. coli and B. fragilis infections
In force
 · High confidence
In forceHigh confidence
US 12,594,312Bacteriophage Compositions for Treating Pseudomonas Infection
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 4 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited